43O A dose-escalation study of TNO155 (TN) in combination with spartalizumab (SPA) or ribociclib (RIB) in adults with advanced solid tumors
| Autor: | Santa Gadea, O. Saavedra, Machiels, J-P., Soo, R.A., Wong, M., Ma, B.B.Y., Zander, T., Wang, Y., Lin, J.J., Gambardella, V., Zhao, J., Nakhla, K., Yang, S., Kodack, D., Moody, S., Yamamoto, N. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|